This radioligand was used for many PET studies to evaluate MAO-B inhibitors’ occupancy [8, 9], pathology of AD [10–12], amyotrophic lateral sclerosis (ALS) [13], traumatic brain injury [14], and epilepsy [15–17]. This evidence concerns the gene MAOB and Alzheimer disease.